Profil
Dr. Angus Lamond is a Director at Dundee Cell Products Ltd.
He is on the Board of Directors at Dundee Cell Products Ltd.
Dr. Lamond was previously employed as a Principal by University Of Dundee and a Principal by The European Molecular Biology Laboratory.
He received his undergraduate degree from the University of Glasgow and a doctorate degree from the University of Cambridge.
Ehemalige bekannte Positionen von Angus Lamond
| Unternehmen | Position | Ende |
|---|---|---|
| University Of Dundee | Corporate Officer/Principal | - |
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - |
DC Biosciences Ltd.
 DC Biosciences Ltd. BiotechnologyHealth Technology DC Biosciences Ltd. provides bioreagents and life science services. The firm’s products include cell extracts, fresh primary mammalian cells, recombinant proteins, steroid beads, fluorescent cell markers, and SILAC reagents. Its services include custom antibody service, custom antibody service, DNA cloning services, gene synthesis service, and protein expression, gene to stable cell line, mass spectrometry, quantitative proteomics, and peptide synthesis. The company was founded by Angus Lamond and Paul Ajuh in June 2006 and is headquartered in Dundee, the United Kingdom. | Gründer | - |
Ausbildung von Angus Lamond
| University of Glasgow | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
DC Biosciences Ltd.
DC Biosciences Ltd. BiotechnologyHealth Technology DC Biosciences Ltd. provides bioreagents and life science services. The firm’s products include cell extracts, fresh primary mammalian cells, recombinant proteins, steroid beads, fluorescent cell markers, and SILAC reagents. Its services include custom antibody service, custom antibody service, DNA cloning services, gene synthesis service, and protein expression, gene to stable cell line, mass spectrometry, quantitative proteomics, and peptide synthesis. The company was founded by Angus Lamond and Paul Ajuh in June 2006 and is headquartered in Dundee, the United Kingdom. | Health Technology |
